Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era
- 31 March 2005
- Vol. 65 (3), 528-532
- https://doi.org/10.1016/j.urology.2004.10.041
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation TherapyJNCI Journal of the National Cancer Institute, 2003
- Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CancerJournal of Urology, 2003
- PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2001
- PSA Doubling Time as a Predictor of Clinical Progression After Biochemical Failure Following Radical Prostatectomy for Prostate CancerMayo Clinic Proceedings, 2001
- USE OF GLEASON SCORE, PROSTATE SPECIFIC ANTIGEN, SEMINAL VESICLE AND MARGIN STATUS TO PREDICT BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMYJournal of Urology, 2001
- PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCERJournal of Urology, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- USING PROSTATE-SPECIFIC ANTIGEN TO ELIMINATE THE STAGING RADIONUCLIDE BONE SCANUrologic Clinics of North America, 1997